Vaccines against human cytomegalovirus: Time to test

Trends in Microbiology

Volumn 4, Issue 1, 1996, Pages 34-38

  Britt, William J ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CYTOMEGALOVIRUS; DRUG DEVELOPMENT; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVIEW; VIRUS INFECTION;

ANIMALIA; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0030033344     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0966-842X(96)81503-4     Document Type: Review

References (47)

1. Chee, M.S. et al. (1990) Curr. Top. Microbiol. Immunol. 154, 125-170
2. Spaete, R.R. et al. (1994) J. Gen. Virol. 75, 3287-3308
3. Griffith, B.P. and Aquino-de Jesus, M.J. (1991) Transplant. Proc. 23, 29-31
4. Shanley, J.D. (1991) Transplant. Proc. 23, S12-S16
5. Mocarski, E.S. (1993) in The Human Herpesviruses (Roizman, B. et al., eds), pp. 173-226, Raven Press
6. Alford, C.A. and Britt, W.J. (1990) in Virology (2nd edn) (Fields, B.N. et al., eds), pp. 1981-2010, Raven Press
7. Meyers, J.D. (1989) Rev. Infect. Dis. 11, S1691-S1705
8. Donaldson, P.T. et al. (1987) Lancet i, 945-948
9. Grattan, M.T. et al. (1989) J. Am. Med. Assoc. 261, 3561-3566
10. Richardson, W.P. et al. (1981) New Engl. J. Med. 305, 57-63
11. Jacobson, M.A. and Mills, J. (1988) Ann. Intern. Med. 108, 585-594
12. Gallant, J.E. et al. (1992) J. Infect. Dis. 166, 1223-1227
13. Munoz, A. et al. (1993) Am. J. Epidemiol. 137, 423-438
14. Fowler, K.B. et al. (1992) New Engl. J. Med. 326, 663-667
15. Griffiths, P.D. et al. (1991) Br. J. Obstet. Gynaecol. 98, 135-140
16. Paya, C.V. et al. (1989) J. Infect. Dis. 160, 752-758
17. Rubin, R.H. and Colvin, R.B. (1986) in Kidney Transplant Rejection: Diagnosis and Treatment (Williams, G.M. et al., eds), pp. 283-304, Dekker
18. Singh, N. et al. (1988) J. Infect. Dis. 158, 124-131
19. Smyth, R.L. et al. (1991) J. Infect. Dis. 164, 1045-1050
20. Grob, J.P. et al. (1987) Lancet i, 774-776
21. Stagno, S. et al. (1986) J. Am. Med. Assoc. 256, 1904-1908
22. Roy, D.M. et al. (1993) J. Gen. Virol. 74, 2499-2505
23. Urban, M. et al. (1992) J. Virol. 66, 1303-1311
24. Adler, S.P. (1989) New Engl. J. Med. 321, 1290-1296
25. Pass, R.F. et al. (1986) New Engl. J. Med. 314, 1414-1418
26. Snydman, D.R. et al. (1987) New Engl. J. Med. 317, 1049-1054
27. Boppana, S.B. and Britt, W.J. (1995) J. Infect. Dis. 171, 1115-1121
28. Boppana, S.B. et al. (1995) J. Infect. Dis. 171, 182-185
29. Adler, S.P. et al. (1995) J. Infect. Dis. 171, 26-32
30. Britt, W.J. et al. (1990) J. Virol. 64, 1079-1085
31. Liu, Y.N. et al. (1991) J. Virol. 65, 1644-1648
32. Marshall, G.S. et al. (1992) J. Infect. Dis. 165, 381-384
33. Pass, R.F. et al. (1981) J. Infect. Dis. 143, 259-265
34. Quinnan, G.V. et al. (1981) J. Immunol. 126, 2036-2041
35. Reusser, P. et al. (1991) Blood 78, 1373-1380
36. Riddell, S.R. et al. (1993) in Multidisciplinary Approach to Understanding Cytomegalovirus Disease (Michelson, S. and Plotkin, S.A., eds), pp. 155-164, Elsevier Science
37. Beninga, J. et al. (1995) J. Gen. Virol. 76, 153-160
38. Stern, H. (1984) in CMV: Pathogenesis and Prevention of Human Infection (Plotkin, S.A. et al., eds), pp. 263-269, Alan R. Liss
39. Plotkin, S.A. et al. (1990) Rev. Infect. Dis. (Suppl.) 12, 827-838
40. Plotkin, S.A. et al. (1991) Ann. Intern. Med. 114, 525-531
41. Plotkin, S.A. et al. (1989) J. Infect. Dis. 159, 860-865
42. Jonjic, S. et al. (1994) J. Exp. Med. 179, 1713-1717
43. Harrison, C.J. et al. (1995) J. Infect. Dis. 172, 1212-1220
44. Rapp, M. et al. (1993) in Multidisciplinary Approach to Understanding Cytomegalovirus Disease (Michelson, S. and Plotkin, S.A., eds), pp. 327-332, Elsevier Science
45. Jonjic, S. et al. (1988) J. Virol. 62, 1653-1658
46. Britt, W. et al. (1995) J. Infect. Dis. 171, 18-25
47. Alp, N.J. et al. (1991) J. Virol. 65, 4812-4820